반응식
I[C:2]1[CH:3]=[C:4]([CH:7]=[C:8](I)[C:9]=1[O:10][CH2:11][O:12][CH2:13][CH2:14][O:15][CH3:16])[CH:5]=[O:6].[C:18]1(B(O)O)[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1.O>COCCOC.C([O-])(=O)C.[Pd+2].C([O-])(=O)C>[CH3:16][O:15][CH2:14][CH2:13][O:12][CH2:11][O:10][C:9]1[C:8]([C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=2)=[CH:7][C:4]([CH:5]=[O:6])=[CH:3][C:2]=1[C:2]1[CH:3]=[CH:4][CH:7]=[CH:8][CH:9]=1참가 물질
6
실험 절차
The title compound was prepared according to the procedure in Example 2, step 3 using 3,5-diiodo-4-(2-methoxyethoxymethoxy)benzaldehyde (4.029 g, 8.721 mmol), phenylboronic acid (2.339 g, 19.19 mmol), palladium(II) acetate (39.16 mg, 0.174 mmol) in DME:H2O. Purification on Biotage KP-Sil eluting with 15% EtOAc/pet. ether gave 1.803 g, (57%) of the title compound. 1H NMR (DMSO-d6) δ 2.78-2.82 (m, 2H), 2.89-2.92 (m, 2H), 3.01 (s, 3H), 4,42 (s, 2H), 7.40-7.54 (m, 6H), 7.62-7.65 (m, 4H), 7.91 (s, 2H), 10.06 (s, 1H).
후처리
- customThe title compound was prepared
- customPurification on Biotage KP-Sil
- washeluting with 15% EtOAc/pet. ether
출처 및 근거
- ORD 기록
- ord-83233f5dca3040a9a3e2cd5714cb1fb2
- 출처 데이터셋
- uspto-grants-2002_09
- 특허 번호
- US06451845B1
연결된 노트
불러오는 중…